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Trypanosoma cruzi, the etiologic Chagas’ disease agent, induces changes in protein pattern of the human placenta syncytiotro-
phoblast. The glucose transporter protein-1 (GLUT1) is the primary isoform involved in transplacental glucose transport. We
carried out in vitro assays to determine if T. cruzi infection would induce changes in placental GLUT1 protein expression under
normal and high concentration of glucose. Using Western blot and immunohistological techniques, GLUT1 expression was
determined in normal placental villi cultured under normal or high concentrations of glucose, with or without in vitro T. cruzi
infection, for 24 and 48hours. High glucose media or T. cruzi infection alone reduced GLUT1 expression. A yet more accentuated
reduction was observed when infection and high glucose condition took place together. We inform, for the ﬁrst time, that T. cruzi
infection may induce reduction of GLUT1 expression under normal and high glucose concentrations, and this eﬀect is synergic to
high glucose concentrations.
1.Introduction
Chagas’ disease, endemic in Latin America, is caused by
Trypanosoma cruzi a ﬂagellated protozoan with a life cycle
involving an insect vector and a mammalian host. The
congenital Chagas’ disease is associated with premature
labor, miscarriage, and placentitis [1]. In endemic countries,
maternal-fetal transmission of T. cruzi is between 1 and 17%
ofpregnanciesinchronicallyinfectedmothers,dependingon
geographic area [2]. The infectious form of the parasite (try-
pomastigote)adherestospeciﬁcreceptorsontheoutermem-
brane of host cells previous to intracellular invasion [3], and
theprocessofinvasionrequiresactivationofsignaltransduc-
tion pathways in the parasite and the host cell [4–10].
Pancreas is one of the organs aﬀected in Chagas’ Disease.
Patients with this disease have plasma pancreatic glucagon
and pancreatic polypeptide levels reduced [11], lower insulin
activity [12], and morphometric and morphologic alter-
ations of pancreatic ganglia and islets [13]. Experimental
infections in hamsters caused pancreatitis, erratic blood
glucose levels, and a tendency to hypoinsulinemia [14].
T. cruzi infection-resistant C57BL/6 mice developed high
parasitemia and mortality when diabetes was induced with
streptozotocin in them [15]. Above clinical and animal
studies suggest that patients with Chagas’ Disease are more
susceptible to develop hyperglycemia, and this would worsen
the infection. In fact, patients with both conditions have
beenreported,anddiabetesorhyperglycemiaprevalencewas2 Journal of Tropical Medicine
higher in patients with the cardiac form of Chagas’ disease
[16].
Hyperglycemia during pregnancy is a well-recognized
pathogenic factor. Adequateglucose transfer from the mater-
nal to the fetal compartment is crucial for the normal
survivalanddevelopmentofthefetusduringpregnancy[17].
GLUT1 is the primary isoform involved in the transplacental
movement of glucose and distributed asymmetrically on the
microvillus and basal membranes syncytiotrophoblast. The
microvillous membrane contains more transporters than the
basal. GLUT is inversely regulated by glucose concentration,
and basal membrane GLUT1 is positively regulated by
insulin-like growth factor I, placental growth hormone, and
hypoxia [18]. In vivo, basal membrane GLUT1 is upregu-
lated over gestation, increased in diabetic pregnancy, and
decreased in chronic hypoxia, while microvillous membrane
GLUT1 is unaﬀected [18, 19]. As the rate-limiting step in
transplacental glucose transport, changes in the density of
basal membrane GLUT1 will have a signiﬁcant impact on
transplacental glucose ﬂux [18, 20].
Although increased expression of GLUT1 in placenta
from diabetic pregnant women has been reported [18, 20],
decreaseinGLUT1mRNAandproteinlevelsindiabeticmice
compared with the control and placental cell cultures under
high glucose concentration conditions was also informed
[20, 21]. Glucose would also alter GLUT1 partitioning
betweentheplasmamembraneandintracellularsitesinfavor
of the latter [22].
In the invasion process, T. cruzi has been found to aﬀect
numerous surface molecules of the placental villi, probably
causing placental dysfunction as consequence. We wondered
if this parasite would somehow also aﬀect GLUT1 expression
pattern, especially under high glucose (HG) concentration,
since T. cruzi has been reported to aﬀect pancreatic function
and alters the insulin-glycemia axis, and there is not yet
a marker for placental or fetus infection. In this work,
we compared the protein expression of GLUT1 of human
placental explants infected in vitro with trypomastigotes,
cultured under normal and high glucose (HG) con-
centration.
2.MaterialsandMethods
2.1. Placentas. Placentas (n = 17) from clinically and sero-
logically healthy women at 38 to 40 weeks of gestation were
obtained by caesarian delivery, in order to assure asepsis.
Women signed an informed consent. Placentas were kept in
glucose solution 0.29mM at 4◦C for transportation. Once
in the laboratory, central villi of placental cotyledons were
isolated, rinsed with PBS several times, and cut into pieces of
3mm in diameter.
2.2. Parasites. Trypomastigotes of T. cruzi (Tulahuen strain)
were isolated according to Andrews and Colli [23]a n d
Fretes and Fabro [24], from infected Albino/Swiss mice
bloodstream at the peak of parasitism. Brieﬂy, mice blood
was centrifuged for 10 minutes at 100g and kept still for 1h
at 37◦C. Plasma was then separated and centrifuged for 10
minutes at 590g. The pellets containing the parasites were
washed twice and suspended in MEM-199 (Gibco Lab., NY,
USA).
2.3. Treatments of Placental Explants. Explants of normal
h u m a np l a c e n t a lv i l l iw e r ec u l t u r e da t3 7 ◦C, in normal
atmosphere supplemented with 5% CO2, in MEM-199 (pH
7) with 0.1% penicillin and 0.01% streptomycin and either
with 5mM D-glucose (normal D-glucose: NG) (J.T. Baker,
NJ, USA) or 25mM D-glucose (high glucose: HG) con-
centrations [22].
After 24 hours, 7 × 105 trypomastigotes Tulahuen strain
of T. cruzi were added with the refresh of culture media,
prepared as mentioned above. Controls without parasites
were carried out for both normal and HG concentrations.
Cocultures with trypomastigotes and controls were incu-
bated for another 24h or 48h.
After treatment, the placental explants were rinsed with
PBS. Part of the explants were ﬁxed with 10% formaldehyde
and included in paraﬃn. Approximately 30mg of placental
explants from each treatment were homogenized in 0.25mL
PBS with an OMNI 1000 homogenizer for ﬁve cycles of high
speed application, each lasting ten seconds.
2.4. Analysis of Placental Explants Infection. At the end of
cultures, placental explants were collected, ﬁxed, and stained
with hematoxylin/eosin and PAS/hematoxylin and observed
under low and high magniﬁcations in a Zeiss Axioskop
20 microscope. Infection of placental explants was assessed
observing amastigote groups of the T. cruzi in trophoblast or
stromal cells of the chorionic villi.
2.5. Immunostaining of GLUT1 Protein Expression in Pla-
cental Explants. Deparaﬃnized histological sections were
embedded in TBS (pH 7.2), pretreated with 0.05% saponin
(15min) for the unmasking of antigens, then with 3% H2O2
(15min) to block internal peroxidases, and treated with
3% nonfat dry milk in TBS (15min) to block nonspeciﬁc
epitopes. GLUT1 protein was detected by incubating the
treated sections with an anti-GLUT1 polyclonal antiserum
(rabbit, CHEMICOM International Inc, Temecula, Calif,
USA) diluted in TBS/Tween (1:500) for overnight, at 4◦C,
and revealed with a secondary antirabbit immunoglobu-
lin conjugated with peroxidase (Sigma-Aldrich Co, Mo,
USA). Peroxidase activity was developed using H2O2/4-Cl-
1-naphthol. Background control without addition of anti-
GLUT1 antiserum was carried out. We also used precultured
placenta controls. Images stored as jpg format were analyzed
with “Image Tool” UTHSCSA version 3.00 (download-
able from http://ddsdx.uthscsa.edu/dig/download.html)a s
described previously [25]. Five optical ﬁelds were measured
per slide; each treatment for each placenta provided 3 slides.
Immunostained area was expressed as ratio of total area
(manually selected surface area).
2.6. Western Blot for GLUT1. Homogenized placental villi
were mixed with lysis buﬀer containing protease inhibitors
(1%w/v de SDS, 1mM EDTA, 1µg/mL of leupeptin,Journal of Tropical Medicine 3
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Figure 1: Paraﬃn-embedded placental villi cultured for 48hs, Pas/H stained. (a) Control placental villi without T. cruzi infection cultured
with normal glucose concentration media; (b) normal placental villi in vitro infected with T. cruzi, cultured with normal glucose media; (c)
normalplacentalvilliculturedunderhighglucoseconcentrationmedia;(d)normalplacentalvilliculturedunderhighglucoseconcentration
media, in vitro infected with T. cruzi. Amastigotes nests were observed inside the villous from infected placentas (arrows). Arrow points
indicate increased glycogen deposits in placental villi explants cultured under HG concentration (c and d). Original magniﬁcation: 1000x.
The scale bar represents 1µm.
100mM of Hepes pH 7.4) and centrifuged at 12000g for 10
minutes. Protein content was measured with Lowry protein
assay [26]. The samples were not heated prior electrophore-
sis; 40µg of sample were loaded per lane in a SDS-PAGE gel
that was carried out with 3% stacking gel and 10% resolving
gel at 200V for 1hr [27] and blotted onto nitrocellulose
at 300mA for 1.5hr using a Trans Blot Mini-Protean II
apparatus (BioRad, Richmond, Calif, USA). GLUT1 on
nitrocellulose was detected with rabbit anti-GLUT1 poly-
clonalantiserum(CHEMICOMInternationalInc,Temecula,
Calif, USA), diluted 1:5000 in TBS-Tween and revealed
with a secondary antirabbit immunoglobulin conjugated
with peroxidase (Sigma-Aldrich Co, Mo, USA). Peroxidase
activity was developed using H2O2/4-Cl-1-naphthol. Back-
ground control without addition of anti-GLUT1 antiserum
andpreculturedplacentacontrolswerecarriedout.Actinwas
detected as a positive control for protein content present in
samples, due the stable expression of this protein.
GLUT1 expression was evaluated with the “Scion image
for windows” program (version: Beta 4.0.2) to measure the
area units marked by Western blot.
2.7. Statistical Analysis. Data were expressed as the mean ±
SEand were analyzedstatistically by ANOVA testfollowed by
“post hoc” LSD Fisher test. Paired t-test was performed, to
establish signiﬁcance between groups (diﬀerent placentas).
A level of less than 5% (P<0.05) was chosen to detect
signiﬁcant diﬀerences.
3. Results
Placental explants showed groups of the reproductive forms
of the parasite (amastigotes) mainly in stromal cells of
the chorionic villi under normal (NG) and high D-glucose
(HG) concentrations, as they were seen in placental villi
slides stained with PAS/H. Furthermore, the presence of
the parasite was more evident when placental explants were
cultured with high D-glucose concentration (Figure 1).
Placental villi explants cultured under HG concentration
(HGC) underwent structural modiﬁcations mainly thick-
ening of the syncytiotrophoblast and basal membranes,
increased glycogen deposits, and a fetal capillary thickening,
similar to those described in the bibliography [28–30]. These
alterations were maintained and also were more notorious
when these placental explants were infected with T. cruzi,
compared to healthy controls incubated with normal glucose
concentration (NGC), as shown in placental sections with
PAS/H staining (Figure 1).
GLUT1 protein was intensively stained on the apical and
basal membrane of the syncytiotrophoblast in controls with
NGC and no infection. The apical expression of GLUT1 was
scarceunderHGC,infectionwithT.cruzi,orbothconditions
together, even thought the label increased in basal area under
these conditions (Figures 2 and 3).
Image quantiﬁcation of immunostained areas showed
that placental explants cultured under HGC per se reduced
the expression of GLUT1 to 34.7% at 24h (Figure 2) and the4 Journal of Tropical Medicine
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Figure2:GLUT1immunodetectioninparaﬃn-embeddedplacentalvillisectionsculturedfor24hours.(a)Uninfectedcontrolplacentalvilli.
GLUT1 expression was intensively marked on the apical and basal syncytiotrophoblast cell membrane (arrows); (b) normal placental villi in
vitro infected with T. cruzi; (c) normal placental villi cultured under high glucose concentration media; (d) normal placental villi cultured
under high glucose concentration media, and in vitro infected with T. cruzi; (e) negative control placental villi (without GLUT1 antiserum
incubation); (f) image quantiﬁcation made by “Image Tool” UTHSCSA version 3.00, which indicates the percentage of the marked area;
values shown are the mean ± SE of four samples from representative experiments (A: control placental villi, without infection; B: infected
normal placental villi; C: normal placental villi cultured under high glucose media; D: infected normal placental villi cultured under high
glucose media; E: negative control placental villi). Original magniﬁcation: 400x. The scale bar represents 1µm. ∗Signiﬁcantly diﬀerent from
the control placental villi (P<0.05; n = 4; paired t-test).
levelofGLUT1proteinexpressionrecoveredto76.3%at48h
(Figure 3). In explants invaded by T. cruzi, the expression
of GLUT1 protein was reduced under both NG and HG
concentrations. At 24h, the protein expression was reduced
to 32% under NGC and to 14.8% under HGC. At 48h, the
GLUT1 protein expression recovered to 37.4% of the initial
levels under NGC and to 48.6% under HGC (paired t-test,
P<0.05).
Western-blotting image of one of the placental samples
as representative of the experiment is shown in Figure 4.
Placental explants cultured under HGC per se reduced the
expressionofGLUT1to40.5%at24handthelevelofGLUT1
protein expression recovered to 56.5% at 48h. In explants
cultured with T. cruzi, the expression of GLUT1 protein
was reduced under both NG and HG concentrations. At
24h, the protein expression was reduced to 59.5% under
NGC and to 20% under HGC. At 48h, the GLUT1 protein
expression was at 52.1% and 14.85% of the initial levels,
in cultures under NG and HG concentrations, respectively
(P<0.05).Journal of Tropical Medicine 5
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Figure 3: GLUT1 immunodetection in paraﬃn-embedded placental villi sections cultured for 48 hours. (a) Uninfected control placental
villi (GLUT1 expression was intensively marked on the apical and basal syncytiotrophoblast cell membrane); (b) normal placental villi in
vitro infected with T. cruzi; (c) normal placental villi cultured under high glucose concentration media; (d) normal placental villi cultured
under high glucose concentration media and in vitro infected with T. cruzi; (e) negative control placental villi (without GLUT1 antiserum
incubation); (f) image quantiﬁcation made by “Image Tool” UTHSCSA version 3.00, which indicates the percentage of the marked area;
values shown are the mean ± SE of seven samples from representative experiments (A: control placental villi, without infection; B: infected
normal placental villi; C: normal placental villi cultured under high glucose media; D: infected normal placental villi cultured under high
glucose concentration media; E: negative control placental villi). Original magniﬁcation: 400x. The scale bar represents 1µm.∗Signiﬁcantly
diﬀerent from the control placental villi (P<0.05; n = 7; paired t-test).
4. Discussion
Diﬀerent authors have reported that diabetics have an
increased susceptibility to a variety of infectious agents [31,
32]. Hyperglycemia has been previously observed to increase
the morbidity and mortality of murine T. cruzi infection
[15]. Diabetes and hyperglycemia were also reported to
be more prevalent in chagasic human patients with the
cardiac form of the disease, than in control ones [16].
But, according to the analysis of the bibliography, there is
not any study analyzing an association between pregnant
women aﬀected with both Chagas’ disease and diabetes
with congenital transmission or with the eﬀect on the new
born. Furthermore, there is no marker for placental or fetus
infection in Chagas’ disease. Due the eﬀect of the Chagas
parasiteonsomeproteinslocatedatthelipidraftofchorionic
villi trophoblast [24, 33], as well as in trophoblast lipids [34],
we aimed to analyze the possible modiﬁcation of the main
glucose transporter located at the syncytiotrophoblast, the
GLUT1 protein, produced by placental T. cruzi infection.
T. cruzi crosses the placental barrier and infects the fetus,
causing the congenital form of the disease [1]. In order to
understand the mechanism used by the parasite to cross this
barrier, the interaction between syncytiotrophoblast plasma6 Journal of Tropical Medicine
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Figure 4: Western blot to detect GLUT1 transporter protein expression in homogenates from normal placental villi, cultured for 24 hours
(a) and 48 hours (b). Actin presence was also detected as a positive control for protein content in samples. GLUT1 expression was evaluated
with the “Scion Image for Windows” program that measured the area units marked. WCN: without culture normal placental villi (positive
control);N:normalplacentalvilli;N+T:normalplacentalvillicoculturedwithT.cruzi;G:normalplacentalvilliculturedunderhighglucose
media; G + T: normal placental villi cocultured with T. cruzi under high glucose media. Values shown are the mean ± SE. ∗Signiﬁcantly
diﬀerent from the control (P<0.05; n = 8; ANOVA test).
membranes from the human placenta and the parasite was
previously studied, with modiﬁcations in lipid and protein
patterns from trophoblast membranes being found [35].
However, the mechanism by which the parasite infects the
placenta as well as the eﬀects upon the protein contents of
the placental barrier is still not well understood.
Our experiments showed that GLUT1 protein expression
was signiﬁcantly diminished in normal placental villi cul-
tured under HGC in vitro infected with T. cruzi, compared to
controls, as was observed by GLUT1 immunodetection and
western blot. Previous studies have shown that the down-
regulation of GLUT1 mRNA expression is correlated with
decreased glucose uptake in placental trophoblasts cultured
under high D-glucose concentration [22]. In the present
work, a signiﬁcant reduction in GLUT1 protein expression
was observed in normal placental syncytiotrophoblast, cul-
turedunderHGCforeither24or48hours.Thiscorroborates
the inverse relation existing between GLUT1 expression and
extracellular glucose concentration, as described by various
authors [18, 20, 36]. Our results are consistent with previous
observationsthatareductioninmRNAexpressionofGLUT1
is induced by a high glucose concentration in cultured
placental trophoblast cells [22, 36–38].
T. cruzi produces plasmatic membrane modiﬁcations, by
altering their lipid [34, 35] and protein components, such
as placental alkaline phosphatase [7–9, 39–41] and GLUT1
protein, as observed in the present study. On the other
hand, we observed in our laboratory, that Gamma-glutamyl
transpeptidase, another enzyme present in the placenta’s
brush border, is not aﬀected in cells cocultured with T. cruzi
[33], suggesting that the parasite aﬀects molecules inserted
in lipid microdomains of the membrane, as PLAP [42]a n d
GLUT1 [43]. As the hyperglycemia characteristic of diabetes
mellitusalsoaﬀectsthesemembranecomponents,wesuggest
that both the parasite and the high glucose conditions could
have been provoking, by diﬀerent ways, a lower placenta
eﬃcacy transporting glucose to fetus. The results obtained
in this work demonstrate that placental explants infected
with T. cruzi induce changes in GLUT1 expression from
human term placenta under high D-glucose concentration.
As a consequence, it is of importance to perform a systematic
study analyzing new born from pregnant women who have
both conditions diabetes and Chagas.
ReducedGLUT1expressionobservedinplacentalculture
with parasites could imply a downregulated GLUT1 activity
in pregnant women with Chagas’ disease. If this disease
is causing damage to pancreas islets [11–13], or happens
together with a previous diabetic condition, the adverse
eﬀects of reduced GLUT1 activity may be exacerbated.
The level of GLUT1 is regulated by glucose concentration,
insulin-like growth factor I, placental growth hormone, and
hypoxia [18]. It would be interesting to further study the
mechanisms by which GLUT1 is aﬀected in Chagas’ disease.
It is likely that the parasite would perturb other components
of the maternal and fetal glucose-insulin-GLUT1 axis. As
glucose and GLUT are inversely regulated, changes in GLUT
expression might alter the insulin level in plasma, pointing
out to determine a marker for placental infection by T. cruzi
in pregnant chagasic women. This matter could be of the
upmost importance in congenital Chagas’ disease.
Histological studies have demonstrated that placentas
from poorly controlled diabetic pregnancies show a thick-
ening of the basal membranes and reduced vascularization
of the villi [30]. Similar to observations reported by other
authors [28, 29], in the present work we detected that
placental villi cultured under high glucose conditions wereJournal of Tropical Medicine 7
morphologically altered, with thickening of the basement
membranes. The presence of T. cruzi maintains this alter-
ation. The parasite causes disorganization of the basal
membraneofthetrophoblastandthestromaofthechorionic
villi [44], as was observed in in vitro experiments similar
to those performed in this work. So, both conditions
hyperglycemia and T. cruzi can modify the stroma of the
chorionic villi. According to our results, the alteration of
the trophoblast basal membrane in the presence of T. cruzi
under high D-glucose concentration might be caused by two
diﬀerent mechanisms or not. This important matter should
be elucidated.
The protein membrane pattern was also altered, as
noted in others works on Placental Alkaline Phosphatase
(PLAP) [7–9, 24, 25, 39–41]; and in the present study
with GLUT1 protein. These characteristics could modify
the human placenta eﬃcacy as a barrier against infections.
It has been described that chorionic villi in vitro has low
susceptibility to infection by T. cruzi in normal D-glucose
concentration [45, 46]. In order to clarify if high D-glucose
concentration can increase the infection of chorionic villi by
T. cruzi, it is necessary to quantify the infection by T. cruzi
of the placental explants under high glucose concentration,
in order to analyze the susceptibility of the invasion and the
reproduction of the parasite in the placenta, aspect that we
are planning to do in further experiments.
With the present work, we report for the ﬁrst time the
eﬀect of T. cruzi on GLUT1 protein expression, adding it to
the increasing list of aﬀected proteins altered by this parasite
[7–9, 24, 25, 40, 41].
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